EU Drug Regulator to Review Ozempic’s Possible Link to Eye Condition
The European Union’s drug regulator said it would review two studies that link Novo Nordisk’s blockbuster diabetes drug Ozempic to a rare eye condition.
Novo Nordisk's Ozempic faces EU review for potential eye disease connection
The European Union's drug regulator said it would assess two new Danish studies that link Novo Nordisk's popular diabetes drug Ozempic to a rare eye disease. The studies published earlier this week had found Ozempic significantly increases the risk of type 2 diabetes patients developing NAION (non-arteritic anterior ischemic optic neuropathy),
EMA to Investigate Eye Risk for Novo’s Ozempic: Reuters
Following an appeal by the Danish Medicines Agency, the European Union’s drug regulator will review two new studies that have strengthened the link between Novo Nordisk’s blockbuster GLP-1 and a rare eye disease.
Diabetes drug linked to increased risk of severe eye condition
Two independent studies from the University of Southern Denmark (SDU) show that patients with type 2 diabetes who are treated with the drug Ozempic have an increased risk of developing damage to the optic nerve of the eye,
Potential Eye Risks Linked to Popular Diabetes Drug Ozempic in Recent Danish Studies
Danish studies have found a potential link between the diabetes drug Ozempic and a rare eye condition called non-arteritic anterior ischemic optic neuropathy (NAION). The Danish Medicines Agency has requested the European Pharmacovigilance Risk Assessment Committee to evaluate these findings,
Novo Nordisk's Ozempic Under Scrutiny For Potential Increased Risk Of Rare-Eye Disease
New studies link diabetes drug Ozempic to increased risk of NAION, a rare eye condition causing vision loss. Danish Medicines Agency calls for European review.
Novo Nordisk's Ozempic potentially investigated for rare eye condition
Denmark's drug regulator has asked the European Medicine Agency's safety committee to evaluate two studies that found a potential link between Novo Nordisk's (NVO) type 2 diabetes drug Ozempic (semaglutide) and a rare eye condition.
Health Officials Investigate Rare Form of Blindness Tied to Ozempic
Several recent studies have found a possible connection between semaglutide use and a rare condition that causes sudden ...
FiercePharma1d
After studies flag possible link between Novo's Ozempic and rare eye disorder, EU plans to investigate: Reuters
It’s not a new question, but it is one that is gaining increased traction: Is there a link between Novo Nordisk’s diabetes ...
Ozempic May Face Investigation Over Vision-Threatening Condition In Some Patients
Danish health authorities asked the European Union to review two studies linking Novo Nordisk's diabetes drug, Ozempic, to a rare eye condition.
Medscape13d
Risk for Ischemic Optic Neuropathy From Glucagon-Like Peptide 1 Receptor Agonists Too Rare to be Detected
A recent meta-analysis of 69 clinical trials found the risk for ischemic optic neuropathy from GLP-1 therapy is too low to be ...
EurekAlert!3d
Danish diabetes medicine increases the risk of severely debilitating eye condition
Two independent studies from the University of Southern Denmark (SDU) show that patients with type 2 diabetes who are treated with the drug Ozempic have an increased risk of developing damage to the ...
Becker's Hospital Review3d
Another study links Ozempic to rare vision loss
Study confirms link between Ozempic's active ingredient and low risk of vision loss. Ophthalmology organizations recommend continued use.
Business Insider6d
Study confirms semaglutide link to increased, but ‘low,’ risk of NAION
A Danish-Norwegian cohort study on the use of semaglutide and risk of non-arteritic anterior ischemic optic neuropathy, or NAION, a rare condition that causes sudden vision loss in one eye due ...